#South Korea #Seoul #Oregon State University #Dr. Oregonin #OLTIS DENTAL-X

Dr. Oregonin Unveils OLTIS DENTAL-X

In a groundbreaking announcement, Dr. Oregonin Inc. has successfully completed their registration with the U.S. Food and Drug Administration (FDA) for their flagship product, OLTIS DENTAL-X. This milestone paves the way for the product's entry into the North American market, introducing a unique blend of science and natural ingredients for oral care.

OLTIS DENTAL-X is not just another toothpaste on the shelf; it is the culmination of 27 years of extensive research led by Professor Sun Eun Choi at Kangwon National University in South Korea. A recognized expert in pharmacognosy and natural products, Professor Choi, along with her dedicated research team, has been pivotal in validating the biological effects of oregonin, a compound derived from Korean alder (Alnus japonica). This compound, previously linked to traditional medicine, has gained recognition for its biological efficacy and has received certification as a National Excellent Technology in South Korea. Moreover, it has been approved by the Ministry of Food and Drug Safety in South Korea, making it a well-regarded entrant in the oral care sector.

The Roots of OLTIS DENTAL-X

The journey of oregonin can be traced back to the Pacific Northwest in 1974, where researchers at Oregon State University isolated a previously unknown compound from the Red Alder tree (Alnus rubra). This discovery introduced oregonin as a polyphenolic diarylheptanoid xyloside, earning its name from the state where it was first identified. Historically, the bark, roots, and leaves of Red Alder have been used in indigenous and local medicinal practices, showcasing an age-old understanding of its health benefits.

Professor Choi's innovative research has verified that the oregonin extracted from Korean alder mirrors the chemical structure and biological activities of the version found in American Red Alder. This remarkable scientific bridge between the U.S. and Korea highlights the potential of utilizing natural resources for health advancements. As Professor Choi eloquently puts it, "Oregonin creates a fascinating scientific bridge between Korea and the United States. The compound was first characterized from America's Red Alder by researchers at Oregon State University. Decades later, our team translated this characteristic Alnus compound into an FDA-registered oral-care innovation."

Path Forward and Market Introduction

Having received FDA approval, Dr. Oregonin Inc. is poised to expand its reach by establishing retail and distribution partnerships across major commercial platforms in the U.S. With OLTIS DENTAL-X, consumers can look forward to a product that not only incorporates the benefits of scientific research but also honors traditional wisdom passed down over generations in various cultures. This unique product stands as a testament to the confluence of American and Korean natural science, promising significant advancements in oral care.

As Dr. Oregonin Inc. continues to promote this innovative oral-care solution, the spotlight is now on the mounting interest from consumers eager to explore a product steeped in natural science and enhanced by rigorous research. OLTIS DENTAL-X represents more than just a new toothpaste; it embodies a collaborative effort, bridging continents and cultures through the recognition of nature's powerful offerings. The future of oral health may just look a bit different, thanks to this exciting new addition to the market.

About Dr. Oregonin Inc.

Dr. Oregonin Inc. specializes in forest-bio research and manufacturing, focusing on the development of natural products, pharmacognosy, and oral-care technology sourced from sustainable forest resources. The company's commitment to innovation embodies a respect for the environment, blending modern science with the wisdom of traditional practices in health care.